Dimas, K.Yerlikaya, Azmi2024-03-052024-03-052014-03-13Ulukaya, E. vd. (2014). "Additive enhancement of apoptosis by TRAIL and fenretinide in metastatic breast cancer cells in vitro". Biomedicine and Pharmacotherapy, 68(4), 477-482.0753-3322https://www.sciencedirect.com/science/article/pii/S0753332214000419https://hdl.handle.net/11452/40199eninfo:eu-repo/semantics/closedAccessBreast cancerCytotoxicityChemotherapyFenretinideTRAILGrowth-inhibitionDeath receptorsCisplatinInductionIdentificationCombinationP53TargetMechanismTrialResearch & experimental medicinePharmacology & pharmacyAntineoplastic combined chemotherapy protocolsApoptosisBlotting, westernBreast neoplasmsCaspase 3Cell line, tumorDrug synergismEnzyme-linked immunosorbent assayFemaleFenretinideHumansMicroscopy, fluorescenceNeoplasm metastasisPoly(adp-ribose) polymerasesTnf-related apoptosis-inducing ligandArticle0003365384000122-s2.0-8490159045247748268424755119https://doi.org/10.1016/j.biopha.2014.03.013Medicine, research & experimentalPharmacology & pharmacyFenretinide; Apoptosis; NeuroblastomaAdenosine triphosphateCaspase 3FenretinideNicotinamide adenine dinucleotide adenosine diphosphate ribosyltransferaseTumor necrosis factor related apoptosis inducing ligandAntineoplastic agentDrug effectsFenretinideApoptosisArticleBreast cancerBreast metastasisCancer cell cultureCell deathCell structureCell viability assayCytotoxicityEnzyme linked immunosorbent assayFluorescence imagingFluorescence microscopyIn vitro studyPolyacrylamide gel electrophoresisPriority journalWestern blottingApoptosisBreast neoplasmsDrug potentiationFemaleHumanMetabolismMetastasisPathologyTumor cell line1950-6007